Intradialytic hypotension and associated factors among patients on maintenance hemodialysis: A single-center study in cameroon

Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia
Marie Patrice HalleAshuntantang E Gloria

Abstract

Intradialytic hypotension (IDH), one of the most frequent acute complications of hemodialysis (HD), is associated with increased patient's morbidity and mortality. The aim of this study was to determine its prevalence and associated factors among patients on maintenance HD in Cameroon. This was a prospective longitudinal study carried out from June 20, to July 30, 2016 (5 weeks), including adult patients on HD >3 months at a tertiary hospital in Douala. During this period, patients were followed up at each HD session, and their blood pressure and occurrence of clinical events possibly related to IDH were recorded. In this study, IDH was defined as a decrease in systolic BP by >20 mm Hg or a decrease in mean arterial pressure by >10 mm Hg, associated to a clinical event. Logistic regression analysis was used to determine associated factors. We included 104 patients (69 males) with a mean age of 50.74 ± 15.18 years and a median duration on HD of 30.5 (interquartile range: 12.25-58.75) years. Hypertension 99/104 (95.2%) and diabetes 32/104 (30.8%) were the main comorbidities encountered. A total of 1032 HD sessions were followed up with an average of 9.88 ± 1.57 sessions per patient. IDH occurred in 11.6% of HD sessions. Associate...Continue Reading

References

Aug 1, 1995·The American Journal of Medicine·M VolterraniP Collins
Aug 1, 1994·Circulation·D M GilliganR O Cannon
Nov 8, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·András TislérIstván Kiss
Mar 20, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Judith A Aberg
Jun 20, 2012·Journal of Nephrology·Davina J TaiJennifer M MacRae
Jan 29, 2014·Hemodialysis International·Jeffrey J SandsJose A Diaz-Buxo
May 8, 2014·International Journal of Cardiology·Guangtao LeiXianfeng Wu
Sep 5, 2014·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Oliver J RiderCameron J Holloway
Oct 2, 2014·Journal of the American Society of Nephrology : JASN·Jennifer E FlytheSteven M Brunelli
Nov 8, 2014·Clinical Journal of the American Society of Nephrology : CJASN·Bergur V StefánssonNils-Olov Stålhammar
Jan 21, 2015·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Rashad S BarsoumFatiu A Arogundade
Mar 18, 2015·Lancet·Thaminda LiyanageVlado Perkovic
Sep 1, 2015·Journal of the American Society of Hypertension : JASH·Ana RochaEva Xavier
Nov 20, 2015·American Journal of Nephrology·Magdalene M Assimon, Jennifer E Flythe
Mar 5, 2016·Kidney & Blood Pressure Research·Ana RochaEva Xavier
Jul 1, 2017·Seminars in Dialysis·Jason A ChouAnna T Mathew

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.